Statements (52)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:approves |
gptkb:legislation
gptkb:United_States gptkb:Native_American_tribe |
| gptkbp:brand |
gptkb:Alesse_21
gptkb:Alesse_28 gptkb:Alesse_7 |
| gptkbp:category |
gptkb:X
|
| gptkbp:class |
combination oral contraceptive
|
| gptkbp:clinical_trial |
gptkb:skincare_product
conducted for safety and efficacy menstrual cycle regulation endometriosis treatment hormonal replacement therapy polycystic ovary syndrome management |
| gptkbp:contraindication |
uncontrolled hypertension
smoking over age 35 liver tumors history of thromboembolic disorders |
| gptkbp:counseling_services |
do not skip doses
take at the same time each day use backup contraception if missed dose |
| gptkbp:dosage_form |
1 mg levonorgestrel and 0.02 mg ethinyl estradiol
|
| gptkbp:effective_date |
gptkb:1999
|
| gptkbp:formulation |
oral tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
Alesse
|
| gptkbp:indication |
contraception
|
| gptkbp:ingredients |
gptkb:ethinyl_estradiol
gptkb:levonorgestrel |
| gptkbp:interacts_with |
antibiotics
antiretrovirals anticonvulsants |
| gptkbp:is_available_in |
gptkb:various_countries
|
| gptkbp:is_effective_against |
over 99% with perfect use
91% with typical use |
| gptkbp:manager |
oral
|
| gptkbp:manufacturer |
gptkb:physicist
|
| gptkbp:marketed_as |
various brand names
|
| gptkbp:packaging |
blister pack
|
| gptkbp:previous_name |
levonorgestrel and ethinyl estradiol
|
| gptkbp:requires |
prescription only
|
| gptkbp:side_effect |
headache
nausea weight gain breast tenderness |
| gptkbp:storage |
room temperature
|
| gptkbp:symptoms |
fatigue
acne mood changes menstrual irregularities |
| gptkbp:bfsParent |
gptkb:Ortho_Tri-Cyclen_Lo
|
| gptkbp:bfsLayer |
5
|